You are here:
diclofenac (Mobigel Spray)
Advice
In the absence of a submission from the holder of the marketing authorisation:
diclofenac 4% spray gel (Mobigel Spray ®): is not recommended for use in NHSScotland.
Indication under review: for the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Drug Details
| Drug Name: | diclofenac (Mobigel Spray) |
|---|---|
| SMC Drug ID: | 667/10 |
| Manufacturer: | Goldshield Pharmaceuticals Limited |
| Indication: | For the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures |
| BNF Category: | |
| Sub Category: | 10.1 Drugs used in rheumatic diseases and gout |
| Submission Type: | Non submission |
| Status: | Not Recommended |
| Date Advice Published: | 13 December 2010 |